ArticleScientific reports2025
Advances in colorectal cancer diagnosis using optimal deep feature fusion approach on biomedical images.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Ensemble CNN for colon cancer detection using histopathological image.Frontiers in oncology · 2026Article
- Could artificial intelligence-powered colonoscopies change the future of colorectal cancer screening?World journal of gastroenterology · 2025Review
- An enhanced fusion of transfer learning models with optimization based clinical diagnosis of lung and colon cancer using biomedical imaging.Scientific reports · 2025Article
- Enhancing clinical diagnosis of laryngeal cancer through fusion-based transfer learning with Osprey Optimisation Algorithm using histology images.Frontiers in oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Colorectal cancer (CRC) is the second popular cancer in females and third in males, with an increased number of cases. Pathology diagnoses complemented with predictive and prognostic biomarker information is the first step for personalized treatment. Histopathological image (HI) analysis is the benchmark for pathologists to rank colorectal cancer of various kinds. However, pathologists' diagnoses are highly subjective and susceptible to inaccurate diagnoses. The improved diagnosis load in the pathology laboratory, incorporated with the reported intra- and inter-variability in the biomarker assessment, has prompted the quest for consistent machine-based techniques to be integrated into routine practice. In the healthcare field, artificial intelligence (AI) has achieved extraordinary achievements in healthcare applications. Lately, computer-aided diagnosis (CAD) based on HI has progressed rapidly with the increase of machine learning (ML) and deep learning (DL) based models. This study introduces a novel Colorectal Cancer Diagnosis using the Optimal Deep Feature Fusion Approach on Biomedical Images (CCD-ODFFBI) method. The primary objective of the CCD-ODFFBI technique is to examine the biomedical images to identify colorectal cancer (CRC). In the CCD-ODFFBI technique, the median filtering (MF) approach is initially utilized for noise elimination. The CCD-ODFFBI technique utilizes a fusion of three DL models, MobileNet, SqueezeNet, and SE-ResNet, for feature extraction. Moreover, the DL models' hyperparameter selection is performed using the Osprey optimization algorithm (OOA). Finally, the deep belief network (DBN) model is employed to classify CRC. A series of simulations is accomplished to highlight the significant results of the CCD-ODFFBI method under the Warwick-QU dataset. The comparison of the CCD-ODFFBI method showed a superior accuracy value of 99.39% over existing techniques.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.